Home Tags Sexually Transmitted Diseases: AIDS/HIV

Tag: Sexually Transmitted Diseases: AIDS/HIV

From 2014 to 2016 there was an increase in the annual number of HIV preexposure prophylaxis (PrEP) users in the United States

2014 to 2016 Saw 470 Percent Increase in HIV PrEP Use in U.S.

~7 percent of those with indications for PrEP were prescribed PrEP, including 2.1 percent of women
Hispanic/Latino women with HIV infection face more socioeconomic and language challenges than men

More Socioeconomic Challenges for Hispanic Women With HIV

Hispanic/Latina women receive more ancillary services than men and have similar clinical outcomes
For criminal justice-involved persons living with HIV

Retention in HIV Care Drops Steadily After Prison Release

Retention in care three years after release linked to older age, having health insurance

September 2018 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for September 2018. This roundup includes...
Among men who have sex with men

HIV Infection Diagnoses on the Rise in Young Homosexual Men

Number of HIV diagnoses in those aged 13 to 29 four times higher than those aged ≥50 years

August 2018 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for August 2018. This roundup includes...
A smartphone app designed for people living with HIV increases users' consistency in doctor visits and improves their health outcomes

Smartphone App Can Help Improve Outcomes With HIV

Improvements seen in retention in care, CD4 counts, and viral suppression
From 1997 to 2015 there was a considerable increase in HIV viral suppression rates among people living with HIV

1997 to 2015 Saw Increase in HIV Viral Suppression Rates

Lower odds of having detectable viral load for older adults and those using ISTI-based regimen
Ibalizumab has antiviral activity among patients with multidrug resistant HIV-1 infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound
Steps should be taken to integrate treatment at the intersection of opioid use disorder and related HIV and hepatitis C virus infectious disease epidemics

Integration of Opioid, Infectious Disease Treatment Needed

Expert panel recommends five action steps for treating opioid abuse and its intersecting epidemics